This Week in HIV Research: Self-Testing Passes a Big Test
This Week in HIV Research: Self-Testing Passes a Big Test
This week, we've got a bevy of intriguing, care-impacting study findings from the world of HIV to share. Our selected research this time around is likely to:
- Alleviate fears that HIV self-testing is inherently less reliable than professional HIV testing.
- Advise the most effective influenza vaccine strategies for people with HIV.
- Inform how age can affect flu vaccine efficacy among HIV-positive people.
- Affirm yet another value to early HIV treatment initiation: CD4:CD8 ratio normalization.
Follow along as we learn more about each of these clinically important findings. To beat HIV, you have to follow the science!
Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.
Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.
Image Credit: CIPhotos for iStock via Thinkstock
This week, we've got a bevy of intriguing, care-impacting study findings from the world of HIV to share. Our selected research this time around is likely to:
- Alleviate fears that HIV self-testing is inherently less reliable than professional HIV testing.
- Advise the most effective influenza vaccine strategies for people with HIV.
- Inform how age can affect flu vaccine efficacy among HIV-positive people.
- Affirm yet another value to early HIV treatment initiation: CD4:CD8 ratio normalization.
Follow along as we learn more about each of these clinically important findings. To beat HIV, you have to follow the science!
Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.
Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.
Image Credit: CIPhotos for iStock via Thinkstock